Items where authors include "Mackie, S.L."
Article
Soowamber, M., Bond, M., Touma, Z. et al. (26 more authors) (2025) A glossary of signs and symptoms of giant cell arteritis. Annals of the Rheumatic Diseases. ISSN 0003-4967 (In Press)
Abacar, K., De Marco, G. orcid.org/0000-0003-2406-161X, Weddell, J. et al. (10 more authors) (2025) Late-Onset Spondylarthritis Presenting as Glucocorticoid-Resistant Polymyalgia Rheumatica: A hitherto underappreciated entity where TNF or IL-17 Blockade may have a Therapeutic Role. Arthritis & Rheumatology. ISSN 2326-5191 (In Press)
Mackie, S.L. orcid.org/0000-0003-2483-5873 and Hill, C.L. (2025) The safety of low-dose methotrexate for rheumatic diseases: looking beyond blood monitoring. Rheumatology. keaf257. ISSN 1462-0324
Zhao, S.S., Mackie, S.L. orcid.org/0000-0003-2483-5873, Larsson, S.C. et al. (2 more authors) (2025) Modifiable risk factors and inflammation-related proteins in polymyalgia rheumatica: genome-wide meta-analysis and Mendelian randomization. Rheumatology, 64 (5). pp. 3012-3018. ISSN 1462-0324
Tieu, J., Cheah, J.T.L., Lyne, S. et al. (9 more authors) (2025) Prioritising domains of glucocorticoid therapy to measure in trials: Results from a modified delphi exercise from the OMERACT glucocorticoid impact working group. Seminars in Arthritis and Rheumatism, 71. 152602. ISSN 0049-0172
Lax, S.J., Dures, E., Bridgewater, S. et al. (12 more authors) (2025) Patient perspectives on the impact of appearance and weight changes attributed to systemic glucocorticoid treatment of rheumatic diseases. Rheumatology. keaf121. ISSN 1462-0324
Chaddock, N.J.M., Harden, C.J., Sorensen, L. et al. (9 more authors) (2025) Age, anticoagulants, hypertension and cardiovascular genetic traits predict cranial ischaemic complications in patients with giant cell arteritis. Annals of the Rheumatic Diseases, 84 (2). pp. 329-340. ISSN 0003-4967
Chaddock, N.J.M., Harden, C.J., Sorensen, L. et al. (10 more authors) (2025) Age, anticoagulants, hypertension and cardiovascular genetic traits predict cranial ischaemic complications in patients with giant cell arteritis. Annals of the Rheumatic Diseases, 84 (2). pp. 329-340. ISSN 0003-4967
Sweeney, A.-M.T., Bridgewater, S., Orme, J. et al. (18 more authors) (2025) Impact of glucocorticoids on patients’ quality of life: a qualitative study assessing face validity and feasibility of the Steroid PRO in patients with inflammatory gastroenterology, respiratory and dermatology conditions. BMJ Open, 15 (2). e089225. ISSN 2044-6055
Shah, S., Rao, S., Mackie, S.L. orcid.org/0000-0003-2483-5873 et al. (1 more author) (2025) A history of polymyalgia rheumatica: a narrative review. Rheumatology, 64 (2). pp. 470-476. ISSN 1462-0324
Quick, V., Abusalameh, M., Ahmed, S. et al. (72 more authors) (2024) Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England. Rheumatology, 63 (12). pp. 3407-3414. ISSN 1462-0324
Keller, K.K., Mukhtyar, C.B., Nielsen, A.W. et al. (35 more authors) (2024) Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica study group. Annals of the Rheumatic Diseases, 83 (11). pp. 1436-1442. ISSN 0003-4967
Khalique, M.I., Arjunan, M., Wood, S. et al. (1 more author) (2024) The spectrum of giant cell arteritis through a rheumatology lens. Eye, 38 (12). pp. 2437-2447. ISSN 0950-222X
Manning, J.E., Harris, E., Mathieson, H. et al. (6 more authors) (2024) Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigue. Journal of Autoimmunity, 147. 103260. ISSN 0896-8411
Borrego-Yaniz, G., Ortiz-Fernández, L., Madrid-Paredes, A. et al. (291 more authors) (2024) Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study. The Lancet Rheumatology, 6 (6). e374-e383. ISSN 2665-9913
Quick, V., Benson, F. and Mackie, S.L. orcid.org/0000-0003-2483-5873 (2024) Life after tocilizumab given for giant cell arteritis: a patient survey and argument for re-treatment. Rheumatology Advances in Practice, 8 (2). rkae054. ISSN 2514-1775
Bridgewater, S., Ndosi, M. orcid.org/0000-0002-7764-3173, Dawson, J. et al. (7 more authors) (2024) Validation of a new glucocorticoid-specific Patient-Reported Outcome Questionnaire (the Steroid PRO). Annals of the Rheumatic Diseases, 83. pp. 394-400. ISSN 0003-4967
Zhao, S.S., Rajeswaran, T., Mackie, S.L. orcid.org/0000-0003-2483-5873 et al. (1 more author) (2024) Genetically proxied IL-1 receptor antagonism and risk of polymyalgia rheumatica. Rheumatology, 63 (2). e43-e44. ISSN 1462-0324
Lim, J., Dures, E., Bailey, L.F. et al. (5 more authors) (2023) Jaw claudication and jaw stiffness in giant cell arteritis: secondary analysis of a qualitative research dataset. Rheumatology Advances in Practice, 8 (1). rkad082. ISSN 2514-1775
Toyoda, T. orcid.org/0000-0001-5784-9281, Armitstead, Z., Bhide, S. et al. (12 more authors) (2023) Treatment of polymyalgia rheumatica: British Society for Rheumatology guideline scope. Rheumatology Advances in Practice, 8 (1). ARTN rkae002. ISSN 2514-1775
Chatzigeorgiou, C. orcid.org/0000-0003-1471-025X, Barrett, J.H., Martin, J. et al. (53 more authors) (2023) Estimating overdiagnosis in giant cell arteritis diagnostic pathways using genetic data: genetic association study. Rheumatology. kead643. ISSN 1462-0324
Chatzigeorgiou, C. orcid.org/0000-0003-1471-025X, Taylor, J.C. orcid.org/0000-0002-2518-5799, Elliott, F. orcid.org/0000-0002-3239-6914 et al. (4 more authors) (2023) Common comorbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank. Rheumatology Advances in Practice, 7 (3). rkad095. ISSN 2514-1775
Maunder, D., Brown, P.M., Barron-Millar, B. et al. (10 more authors) (2023) Micro-RNA content of circulating extracellular vesicles in early rheumatoid arthritis as biomarkers and mediators of methotrexate efficacy. Rheumatology. kead569. ISSN 1462-0324
Almeida, D.E., Smith, K., Sarker, B.A. et al. (3 more authors) (2023) Does the halo count on temporal and axillary ultrasound predict time to relapse in giant cell arteritis? Rheumatology, 62 (11). pp. 3710-3714. ISSN 1462-0324
Bridgewater, S., Shepherd, M.A., Dawson, J. et al. (19 more authors) (2023) Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment–specific patient-reported outcome measure. Rheumatology, 62 (11). pp. 3565-3575. ISSN 1462-0324
Schmidt, W.A., Dasgupta, B., Sloane, J. et al. (13 more authors) (2023) A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis. Arthritis Research & Therapy, 25. 199. ISSN 1478-6354
Bosch, P. orcid.org/0000-0002-6783-6422, Bond, M. orcid.org/0000-0002-5400-2955, Dejaco, C. orcid.org/0000-0002-0173-0668 et al. (5 more authors) (2023) Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: a systematic literature review and meta-analysis informing the 2023 update of the EULAR recommendations. RMD Open, 9 (3). e003379. ISSN 2056-5933
Bosch, P., Bond, M., Dejaco, C. et al. (5 more authors) (2023) Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: a systematic literature review and meta-analysis informing the 2023 update of the EULAR recommendations. RMD Open, 9 (3). e003379. ISSN 2056-5933
Taze, D. orcid.org/0000-0002-0275-5365, Chakrabarty, A., Venkateswaran, R. et al. (5 more authors) (2023) Histopathology reporting of temporal artery biopsy specimens for giant cell arteritis: results of a modified Delphi study. Journal of Clinical Pathology. ISSN 0021-9746
Mackie, S.L., Twohig, H., Neill, L.M. et al. (10 more authors) (2017) The OMERACT core domain set for outcome measures for clinical trials in polymyalgia rheumatica. The Journal of Rheumatology, 44 (10). pp. 1515-1521. ISSN 0315-162X
Twohig, H., Jones, G., Mackie, S.L. et al. (2 more authors) (2017) Assessment of the face validity, feasibility and utility of a patient-completed questionnaire for polymyalgia rheumatica: a postal survey using the QQ-10 questionnaire. Pilot and Feasibility Studies, 2017 (4). 7. ISSN 2055-5784
Proceedings Paper
O'Brien, A.V., Eng, S., Mackie, S.L. et al. (8 more authors) (2024) P182 Exercise and activity in polymyalgia rheumatica: co-creating an education resource acceptable to patients and health professionals. In: Rheumatology. British Society for Rheumatology Annual Conference 2024, 24-26 Apr 2024, Liverpool, UK. Oxford University Press (OUP) , i120.
![[up]](/style/images/multi_up.png) Up a level
 Up a level